Search results
Author(s):
Rajesh Kharbanda
Added:
6 months ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Author(s):
Harriette Van Spall
,
Rajesh Kharbanda
Added:
7 months ago
ACC 25 - PROTECT-TAVI shows no benefit to routine use of cerebral embolic protection during transcatheter aortic valve implantation (TAVI).Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK) to discuss the findings from the British Heart Foundation's PROTECT-TAVI Trial, which aimed to determine whether using…
View more
Author(s):
Sunny Goel
Added:
5 months ago
New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.Interview…
View more
Author(s):
Ralf Westenfeld
Added:
1 year ago
Stroke Following TAVR in Women
Author(s):
Mirvat Alasnag
,
Giulia Masiero
,
Chiara de Biase
,
et al
Added:
1 month ago
Article
Author(s):
Rajesh Kharbanda
,
Tessel Vossenberg
Added:
2 years ago
In this exclusive interview, Dr Tessel Vossenberg (Medical Center Leeuwarden, Leeuwarden, NL) speaks with Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK),Principal Investigator of the BHF PROTECT TAVI trial.This highly anticipated trial aims to provide groundbreaking insights into the field of Cerebral Embolic Protection (CEP) in TAVI.
In this interview, Dr…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
7 months ago
Step into the forefront of interventional cardiology with distinguished experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they provide a comprehensive overview of EuroPCR 2025's most anticipated late-breaking trials.Optimize your conference preparation through this essential preview, where expert commentary outlines the clinical significance of this…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
6 months ago
Explore the Top Trials from EuroPCR 25 with Insights from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at EuroPCR.In this comprehensive EuroPCR review, interventional experts examine the most significant trials, providing valuable insights into their impact on current practices…
View more
Author(s):
Frederick Welt
Added:
1 month ago
Uncover emerging insights into acute myocardial infarction management with Dr Frederick WeltThis presentation, part of the Complex Cases track in Women As One's CLIMB® 2025 Skills Training Program, explores contemporary challenges in STEMI care. Dr Welt examines reperfusion injury and its role as a potential therapeutic target, discussing why advances in treatment timing alone may not be…
View more
Author(s):
Dan Lenihan
,
,
Start date:
Mar 13, 2025
Join Dr Miguel N. Menezes, (Santa Maria University Hospital, PT), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) as they explore the vital role of cardio-oncology in managing cardiovascular complications that arise from cancer treatments.The experts will discuss innovative interventional strategies to optimise heart health in cancer…
View more